Celiac Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Celiac disease is an immune-mediated disorder characterized by small intestinal enteropathy, systemic malabsorption and immune activation symptoms, and autoantibodies to tissue transglutaminase (TTG). It is unique among autoimmune diseases in that the trigger, dietary gluten, has been identified, and removing it results in the resolution of symptoms and enteropathy in most patients. The undiagnosed celiac disease might have severe consequences in children and adult subjects. Celiac disease's primary mechanism is an abnormal adaptive immune response to gluten-derived peptides. Prolamines have been found to contain critical epitopes presented by either HLA-DQ2 or HLA-DQ8 that induce a CD4+ T-lymphocyte response. Celiac disease can be severe as it can cause long-lasting digestive problems and keep the body from getting all the necessary nutrients. It can also affect the body outside the intestine. · The prevalence of Celiac disease varies from 4...